The first Checkpoint Therapeutics trade was made in Q2 2020.
Since then Ken Griffin bought shares eight more times and sold shares on ten occasions. The investor completely sold their stake between Q4 2024 and Q1 2025.
Avg closing price
Price range
Sold -263 shares
Q1 2025
Avg closing price
$3.33
Price range
$2.38
-
$4.07
Sold 98.0% shares (-12.9k shares)
Q4 2024
Avg closing price
$3.41
Price range
$2.18
-
$4.39
New holding (+13.1k shares)
Q3 2024
Avg closing price
$2.31
Price range
$2.05
-
$2.68
Sold -6.69k shares
Q2 2024
Avg closing price
$1.78
Price range
$1.39
-
$2.15
New holding (+6.69k shares)
Q1 2024
Avg closing price
$1.99
Price range
$1.68
-
$2.44
Sold -1.9k shares
Q4 2023
Avg closing price
$2.18
Price range
$1.61
-
$3.32
Increased shares by 149.7% (+1.14k shares)
Q3 2023